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Abstract
Background: Pleural ﬂuid (PF) may be transudative or exudative. Total protein estimation from PF is used to detect
exudative pleural effusion.
Objectives: To determine the role of new suggested criteria consisting of lactate dehydrogenase (LDH), total proteins (TP),
and adenosine deaminase (ADA) in diagnosis of pleural effusion and differentiate it into transudative and exudative and
also to compare it with Light’s criteria.
Materials and Methods: This was a cross-sectional study comprising 101 patients with pleural effusion, classiﬁed by
previously established criteria as transudates or exudates. The study was carried out in a 550-bedded tertiary-care, rural-
based, teaching hospital for 1 year. Diagnostic parameters mentioned in Light’s criteria were performed from PF and
serum, whereas parameters of the new criteria used in our study (LDH, TP, and ADA) were performed from PF. Receiver-
operating characteristic curve was used to determine the cutoffs, multiple parallel tests were applied to combine individual
test markers to optimize diagnostic accuracy and sensitivity, and speciﬁcity and diagnostic accuracy for each test were
calculated.
Results: After using multiple parallel tests, the sensitivity, speciﬁcity, and accuracy of Light’s criteria for diagnosing
exudates were 98.9%, 75%, and 95% and those for transudates were 95.29%, 80%, and 93%, respectively. Whereas for
the proposed new criteria, sensitivity, speciﬁcity, and accuracy for diagnosing exudates were 98.81%, 93.75%, and 98%
and those for transudates were 95.23%, 87.5%, and 94%, respectively. The accuracy of new criteria was comparable to
that of Light’s criteria (p = 0.0018).
Conclusion: From our study, it can be concluded that PF analysis of LDH, TP, and ADA has high sensitivity and speciﬁcity
for diagnosing pleural effusions and can be used as useful markers to suggest exudative effusions.
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Introduction
Pleural effusion can be classiﬁed as transudative and
exudative.[1] Estimation of total proteins (TP) from pleural ﬂuid
(PF) is routinely used to differentiate transudates from
exudates with a cutoff of 3 g/dL, frequently being used but
many times this has led to the misinterpretation of effusions.[2,3]
To ﬁnd parameters that can differentiate transudates from
exudates, Light et al. proposed the criteria in 1972, according
to which pleural effusion is likely to be exudative if at least one
of the following exists: (1) the ratio of PF protein to serum
protein greater than 0.5; (2) the ratio of PF lactate dehydro-
genase (LDH) and serum LDH greater than 0.6; and (3) PF
LDH greater than 2/3 times the normal upper limit of serum
LDH.[1] Different laboratories have different values for the upper
limit of serum LDH, that is, 200 and 300 U/L,[4] the sensitivity of
which is good but speciﬁcity is not satisfactory.[5] Hence,
several other studies were carried out to propose classiﬁca-
tions that included estimation of PF cholesterol,[6,7] ratio of PF/
serum cholesterol, PF/serum bilirubin,[7,8] and albumin gradi-
ent.[9,10] Later many studies were carried out on adenosine
deaminase (ADA),[11,12] which proved that it is a useful
biochemical marker to differentiate transudates from exudates.
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The aim of this study was to assess the clinical utility of PF
LDH, TP, and ADA in the diagnosis and differentiation of
transudative and exudative pleural effusion. The rationale of
this study was also to compare the usefulness of the new
criteria with classical Light’s criteria.
Materials and Methods
This was an observational, cross-sectional study compris-
ing 101 samples of PF and venous blood from different patients
of pleural effusion from the medical wards and intensive care
units of a tertiary-care hospital between February 1, 2013 and
December 31, 2013. Tuberculous effusion was diagnosed by
culture examination of PF and pleural tissue, or on the basis of
pleural biopsy. Malignant effusions were diagnosed on the
basis of cytopathological investigations. We excluded those
cases of effusion in whom cause was not identiﬁed despite
exhaustive investigations. We excluded samples of patients
with hemothorax, on diuretic therapy, on anticoagulant or
thrombolytic agents, and tested positive for HIV. Other causes
of effusions were already diagnosed on the basis of all clinical
data and investigations. We also excluded hemolyzed, lipemic,
icteric, and ﬁbrin-containing ﬂuid samples. Samples of PF and
venous blood were obtained in plain vacutainer and immedi-
ately centrifuged for 15 min at 3000 rpm. The supernatant ﬂuid
and serum were separated and measurements of LDH, TP, and
ADA were taken. TP was estimated using colorimetric endpoint
biuret method whereas LDH was estimated using colorimetric
assay DGKC (pyruvate to lactate), both were performed on
Cobas Integra 400 plus autoanalyzer (Roche). ADA was
analyzed using colorimetric endpoint method on RA-50
semi-autoanalyzer.
Statistical Analysis
Statistical analysis was performed using MedCalc software,
version 12.5. Values of p o 0.05 were considered signiﬁcant.
The receiver-operating characteristic (ROC) curve was used to
determine the cutoff or reference value of each parameter.
Multiple parallel tests were applied to combine individual test
markers to optimize diagnostic accuracy. Combined ROC
curves were also obtained after applying multiple parallel tests
to compare the signiﬁcance. We calculated sensitivity, speci-
ﬁcity, and diagnostic accuracy for each test with a 95%
conﬁdence interval (95% CI) to evaluate diagnostic or validity
parameters of a given test. We used positive and negative
likelihood ratios as overall indicators of concordance.
Results
Table 1 shows the distribution of the causes of exudates
(in 85 patients) and transudates (in 16 patients) in the cases
under study. Among patients with exudates (60 males and 25
females), the mean age was 45.2 years (range 15–50 years).
However, in case of transudates (9 men and 7 women), the
mean age was 61.5 years (range 40–89 years). Among
patients with exudates, 76% had tuberculosis whereas 14%
had lung carcinoma and 2% had systemic lupus erythemato-
sus (SLE). In case of transudates, 50% patients had
congestive cardiac failure (CCF), 25% chronic renal failure,
and 13% cirrhosis. While hypoproteinemia and cirrhosis were
constituting 6% each as the cause of transudates.
Table 2 shows analysis of the diagnostic parameters
included in Light’s criteria, which include ratio of LDH in PF
and serum (LDH-PF/S), ratio of TP in PF and serum (TP-PF/
S), and LDH in PF (LDH-PF). These parameters were run as
isolated tests for the diagnosis of transudates and exudates.
From the analysis it is evident that in case of exudates, the
sensitivity and speciﬁcity of LDH-PF/S ratio are 84.52% (95%
CI: 74.62–91.18) and 68.75% (95% CI: 41.48–87.87), respec-
tively, which shows low speciﬁcity. However, sensitivity and
speciﬁcity of TP-PF/S ratio in case of exudates are 95.18%
(95% CI: 87.45–98.44) and 70.59% (95% CI: 44.05–88.62),
respectively, and those of LDH-PF ratio are 91.76% (95% CI:
83.24–96.34) and 60% (95% CI: 32.89–82.54), respectively,
which show very low speciﬁcity as compared to other
diagnostic parameters. The cutoff point of LDH-PF was 200
U/L as recommended in Light’s criteria. Thus, it is evident that
in case of exudates if we run these parameters as isolated
tests then the speciﬁcity is very low. On the contrary, it is
evident that in case of transudates the speciﬁcity is on higher
side as compared to exudates. For example, the speciﬁcity of
Table 1: Proportions of patients diagnosed with various diseases who presented with pleural exudates and transudates
Classiﬁcation Diagnoses Patients, n (%) Males Females
Exudate, N = 85 Tuberculosis 65 (76) 46 19
Small-cell lung carcinoma 1 (1) 01 00
Non-small-cell lung carcinoma 10 (13) 07 03
Systemic lupus erythematosus 2 (2) 01 01
Pleural empyema 7 (8) 05 02
Transudate, N = 16 Congestive cardiac failure 8 (50) 05 03
Chronic renal failure 4 (25) 02 02
Hypoproteinemia 1 (6) 00 01
Cirrhosis 2 (13) 01 01
Atelectasis 1 (6) 01 00
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LDH-PF/S ratio in case of transudates is 94.74% (95%
CI: 71.89–99.72) against 68.75% in case of exudates, that of
TP-PF/S ratio is 85.71% (95% CI: 42–99.25) against 70.59%
in case of exudates, and that of LDH-PF for transudates is
91.67% (95% CI: 59.75–99.56) against 60% in case of
exudates. Hence, in case of the parameters included in Light’s
criteria, both sensitivity and speciﬁcity are not higher for
exudates or transudates. If sensitivity was higher then
speciﬁcity was lower and vice versa. To get high sensitivity
and speciﬁcity, we performed analysis of ADA from PF and it
was found that in case of exudates, sensitivity of ADA-PF was
96.47%, speciﬁcity was 86.67%, and diagnostic accuracy
was 95%, which was higher than that of parameters of Light’s
criteria. In case of transudates, the sensitivity, speciﬁcity,
and diagnostic accuracy were 95.23%, 75%, and 92%,
respectively. Hence, the sensitivity and accuracy were better
although speciﬁcity was lower. Table 2 also comprises other
related statistical data of the diagnostic parameters run as
isolated tests.
Table 3 summarizes the analysis of diagnostic parameters
of Light’s criteria for the diagnosis of transudates and
exudates, which were run as multiple parallel tests using
LDH and TP. Using multiple parallel tests, we found the
sensitivity, speciﬁcity, and diagnostic accuracy to be 98.9%,
75%, and 95% respectively for diagnosis of pleural exudates,
whereas the corresponding values for the diagnosis of pleural
transudates were 95.29%, 80%, and 93%, respectively. It is
evident that speciﬁcity is still lower in both transudates and
exudates despite using multiple parallel tests.
To distinguish exudates from transudates, we determined
the best cutoff points or reference values for LDH-PF, TP-PF,
and ADA-PF with the help of the ROC curve. That is, to
determine LDH-PF, the cutoff point to distinguish exudates
from transudates was 325 U/L, which means 4325 U/L
indicates exudate and r325 U/L indicates transudate. The
area under ROC curve (AUC) was 0.956 (p o 0.0001).
Regarding TP-PF, the cutoff point to distinguish exudates from
transudates was 3.4 mg/dL, which means 43.4 mg/dL
indicates exudate and r3.4 mg/dL indicates transudate. The
AUC was 0.892 (p o 0.0001). Regarding ADA-PF, the cutoff
point to distinguish exudates from transudates was 35 U/L,
which means 435 U/L indicates exudate and r35 U/L
indicates transudate. The AUC was 0.922 (p o 0.0001).
Table 4 shows the analysis of the diagnostic parameters of
new criteria for exudates and transudates after applying
multiple parallel tests for LDH-PF, TP-PF, and ADA-PF. For
the diagnosis of exudates, the sensitivity, speciﬁcity, and
accuracy were 98.81%, 93.75%, and 98%, respectively,
whereas in case of transudates, the corresponding values
were 95.23%, 87.5%, and 94%. It is evident that the diagnostic
parameters of the new criteria are comparable to those
included in Light’s criteria.
Table 2: Analysis of diagnostic parameters as isolated tests
Diagnosis Parameters LDH-PF/S TP-PF/S LDH-PF ADA-PF
Exudates Prevalence 84.15% (75.01–90.3) 83.14% (73.89–89.5) 85.2% (76.15–91.08) 85.19% (76.15–91.08)
Sensitivity 84.52% (74.62–91.18) 95.18% (87.45–98.44) 91.76 (83.24–96.34) 96.47% (89.32–99.08)
Speciﬁcity 68.75% (41.48–87.87) 70.59 (44.05–88.62) 60% (32.89–82.54) 86.67% (58.39–97.66)
PPV 93.42% (84.66–97.55) 94.05 (86.04–97.79) 92.86 (84.53–97.06) 97.62% (90.86–99.59)
NPV 45.83% (26.17–66.76) 75% (47.41–91.67) 56.25 (30.55–79.24) 81.25% (53.69–95.03)
Signiﬁcance (p) o0.0001 o0.0001 o0.0001 o0.0001
Accuracy 82% (79.3–84.8) 91% (87.3–95.8) 87% (82.3–91.7) 95% (91.8–98.3)
PLR (C) 2.7 (1.3–5.62) 3.24 (1.55–6.77) 2.29 (1.23–4.28) 7.24 (1.99–26.31)
NLR (C) 0.23 (0.13–0.39) 0.07 (0.03–0.19) 0.14 (0.06–0.30) 0.04 (0.01–0.13)
PLR (W) 14.2 (6.07–33.2) 15.8 (6.74–37.03) 13 (6–28.17) 41 (10.42–161.3)
NLR (W) 1.18 (0.74–1.88) 0.33 (0.14–0.81) 0.78 (0.41–1.49) 0.23 (0.08–0.66)
Transudates Prevalence 81.14% (71.67–87.89) 83.16% (78.62–86.9) 82.15% (76.6–88.4) 84.16% (75–90.3)
Sensitivity 86.42% (76.58–92.7) 69.9% (59.37–78.74) 68.18% (57.28–77.48) 95.24% (87.59–98.46)
Speciﬁcity 94.74% (71.89–99.72) 85.71% (42–99.25) 91.67% (59.75–99.56) 75% (47.4–91.67)
PPV 98.8% (91.35–99.92) 98.48% (90.73–99.92) 98.36% (90.02–99.91) 95.24% (87.59–98.46)
NPV 0.62 (0.42–0.79) 17.65% (7.39–35.17) 28.21% (15.55–45.1) 75% (47.4–91.67)
Signiﬁcance (p) o0.0001 o0.0001 o0.0001 o0.0001
Accuracy 88% (84.5–91.5) 93% (89.2–96.8) 71% (68.2–73.8) 92% (88.8–95.2)
PLR (C) 16.42 (2.43–110.8) 4.89 (0.79–30.18) 8.18 (1.25–53.72) 3.81 (1.63–8.91)
NLR (C) 0.14 (0.08–0.25) 0.35 (0.25–0.5) 0.35 (0.25–0.48) 0.06 (0.02–0.17)
PLR(W) 70 (10–490) 65 (9.29–454.7) 60 (8.59–419.24) 20 (7.68–52.1)
NLR(W) 0.61 (0.37–1.01) 4.67 (3.05–7.14) 2.55 (1.84–3.52) 0.33 (0.14–0.81)
LDH-PF/S, ratio of lactate dehydrogenase in pleural ﬂuid and serum; TP-PF/S, ratio of total proteins in pleural ﬂuid and serum; LDH-PF, LDH in
pleural ﬂuid; ADA-PF, adenosine deaminase in pleural ﬂuid; PPV, positive predictive value; NPV, negative predictive value; PLR, positive
likelihood ratio; C, conventional; NLR, negative likelihood ratio; W, weighted by prevalence.
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Table 3: Analysis of diagnostic parameters of Light’s criteria for the diagnosis of pleural exudates and transudates
Estimated value 95% Conﬁdence interval
Lower limit Upper limit
Exudates
Sensitivity 98.90% 95% 99.95%
Speciﬁcity 75% 52.95% 89.40%
Positive predictive value 95.42% 89.87% 98.12%
Negative predictive value 94.74% 71.89% 99.72%
Accuracy 95% 92.20% 98.10%
Likelihood ratios: (C) = conventional; (W) = weighted by prevalence
Positive (C) 3.97 1.98 7.94
Negative (C) 0.01 0.001 0.076
Positive (W) 20.83 9.52 45.56
Negative (W) 0.056 0.008 0.376
Transudates
Sensitivity 95.29% 87.73% 98.48%
Speciﬁcity 80% 51.37% 94.68%
Positive predictive value 96.42% 89.19% 99.07%
Negative predictive value 75% 47.40% 91.67%
Accuracy 93% 89.90% 96.10%
Likelihood ratios: (C) = conventional; (W) = weighted by prevalence
Positive (C) 4.76 1.73 13.12
Negative (C) 0.06 0.02 0.16
Positive (W) 27 8.88 82.09
Negative (W) 0.33 0.14 0.81
Table 4: Analysis of diagnostic parameters of new criteria for the diagnosis of pleural exudates and transudates
Estimated value 95% Conﬁdence interval
Lower limit Upper limit
Exudates
Sensitivity 98.81% 92.62% 99.94%
Speciﬁcity 93.75% 67.71% 99.67%
Positive predictive value 98.81% 92.62% 99.94%
Negative predictive value 93.75% 67.71% 99.67%
Accuracy 98% 94.40% 99.92%
Likelihood ratios: (C) = conventional; (W) = weighted by prevalence
Positive (C) 15.81 2.37 105.47
Negative (C) 0.01 0.001 0.089
Positive (W) 83 11.83 582.45
Negative (W) 0.067 0.010 0.448
Transudates
Sensitivity 95.23% 87.59% 98.46%
Speciﬁcity 87.5% 60.41% 97.8%
Positive predictive value 97.56% 90.65% 99.58%
Negative predictive value 77.78% 51.92% 92.63%
Accuracy 94% 90.8% 97.2%
Likelihood ratios: (C) = conventional; (W) = weighted by prevalence
Positive (C) 7.62 2.08 27.88
Negative (C) 0.05 0.02 0.14
Positive (W) 40 10.17 157.3
Negative (W) 0.29 0.12 0.70
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Table 5 summarizes the comparison of diagnostic accu-
racy of the new criteria of our study with that of Light’s criteria.
The diagnostic accuracy of new criteria proposed for the
diagnosis of exudates was signiﬁcantly comparable with that
of Light’s criteria. Furthermore, combined ROC curves for
Light’s criteria and new criteria were obtained after applying
multiple parallel tests.
Figure 1 shows that the AUC for Light’s criteria was 0.884
(p o 0.0001) whereas that for new criteria was 0.906 (p o
0.0001). Hence, it is concluded that new criteria is signiﬁcantly
comparable to Light’s criteria.
Discussion
Because pleural effusion is due to an underlying disease, it
must be differentiated into transudate or exudate to know its
exact etiopathology so that appropriate management can be
done. Transudate occurs in conditions such as congestive
heart failure, pneumonia, atelectasis, and mediastinal carci-
nomatosis, whereas an exudate results from diseases such as
tuberculosis, carcinoma lung, SLE, and empyema.[2] To
distinguish exudates from transudates, LDH, TP, and ADA
were used and the cutoffs were determined with the help of
ROC curve. The values for AUC were calculated with a
trapezoidal method,[13] with values close to 1.0 indicating high
diagnostic accuracy.[14,15] We then calculated sensitivity, speci-
ﬁcity, and diagnostic accuracy by applying multiple parallel tests.
Maranhão et al.[16] conducted a similar study in which the
sensitivity, speciﬁcity, and accuracy were 99.4%, 72.6%, and
99.2%, respectively, for the diagnosis of exudates whereas in
case of transudates, the corresponding values were 98.5%,
83.4%, and 90%. This clearly states that the speciﬁcity in the
diagnosis of exudates and transudates is signiﬁcantly lower as
against our study, which can lead to misclassiﬁcation of
exudates and transudates. This was probably because they
had used only two parameters, namely LDH and TP using
multiple parallel tests whereas we included ADA in addition to
LDH and TP and applied multiple parallel tests. Furthermore,
the reason behind high sensitivity and low speciﬁcity in case of
their study could be that they decided a cutoff of LDH as 328
U/L against 325 U/L in our study. In our study, the cutoff values
were uniformly selected using a formal technique that maxi-
mized sensitivity without markedly decreasing speciﬁcity. This
technique suggests that the fundamental feature of diagnostic
tests is a linkage between sensitivity and speciﬁcity, which
produces a relatively large decrease in speciﬁcity for a small
gain in sensitivity when cutoff values are selected to decrease
false-negative results to an extreme degree. Bearing this in
mind, cutoff points were determined such that speciﬁcity would
not be compromised by marginally increasing sensitivity.[17]
In our study, we obtained diagnostic parameters that were
comparable to those included in Light’s criteria.[1] It is evident
that the sensitivity of diagnostic parameters of Light’s criteria
as isolated tests is low in case of transudates, which may lead
to misclassiﬁcation of a transudate as an exudate. Whereas in
case of exudates, speciﬁcity of those parameters was low that
may lead to misclassiﬁcation of exudates and transudates.
Hence, it is advantageous to use multiple parallel tests that will
improve the overall sensitivity and speciﬁcity. By applying
multiple parallel tests in case of diagnostic parameters of Light’s
criteria, the sensitivity, speciﬁcity, and diagnostic accuracy
were 98.9%, 75%, and 95%, respectively, whereas in case of
transudates, the corresponding values were 95.29%, 80%, and
93%. Light’s criteria may have almost 100% sensitivity in
diagnosis of exudates but approximately 20% patients with
pleural effusion that was caused by CCF may fulﬁll the criteria
of exudative effusion after being treated with diuretics and
hence may be misdiagnosed.[18] This clearly states that the
lower speciﬁcity can lead to misclassiﬁcation of transudates as
exudates. Another advantage of our study is that all tests are to
Figure 1: Comparison of combined ROC curve of Light’s criteria and
new criteria
Table 5: Comparison between Light’s criteria and new criteria
Diagnosis Diagnostic yield (accuracy) Sensitivity Speciﬁcity Combined ROC curve
Light’s
criteria
New
criteria
p-Value Light’s
criteria
New
criteria
Light’s
criteria
New
criteria
Light’s criteria New criteria
Exudate 95% 98% 0.0018 98.9% 98.81% 75% 93.75% 0.884 (p o 0.0001) 0.906 (p o 0.0001)
Transudate 93% 94% 0.916 95.29% 95.23% 80% 87.5%
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be performed from PF only, whereas in case of Light’s study,
both blood and PF samples have to be collected to perform
LDH-PF/S and TP-PF/S. Hence, more number of tests will be
used and it will increase the cost as well.
Atalay et al.[11] carried out a study on ADA and proved that
it was a useful biochemical marker to differentiate transudates
from exudates, and it was equally sensitive and speciﬁc as
albumin gradient. In case of exudates, the sensitivity and
speciﬁcity were 85.8% and 82.3%, respectively, which were
lower as compared to our study. The limitation of this study
was that it included only exudates, whereas in our study both
exudates and transudates were included.
Heffner et al.[19] conducted a meta-analysis of diagnostic
tests that were used to distinguish exudative from transudative
pleural effusion wherein they used a number of parameters
that included LDH-PF, TP-PF, and cholesterol-PF (C-PF).
They derived cutoff points for each parameter and processed
them as paired and triplet combinations, that is, LDH-PF/C-PF
and TP-PF/LDH-PF/C-PF, respectively. For the diagnosis of
exudative effusion, the sensitivity and speciﬁcity of LDH-PF/C-PF
were 97.5% and 71.9%, respectively, whereas the correspond-
ing values for TP-PF/LDH-PF/C-PF were 98.4% and 70.4%.
It is evident that speciﬁcity is much lower as compared to
our study, which could be because we have replaced
cholesterol by ADA.
Conclusion
From this study it can be concluded that PF analysis of
LDH, TP, and ADA is easy, simple, cost-effective, and has high
sensitivity, speciﬁcity, and accuracy for the diagnosis of pleural
effusions. By using combined ROC curve it can be concluded
that the new criteria is signiﬁcantly comparable to Light’s
criteria. The use of new criteria of our study is effective and
satisfactory as its diagnostic accuracy is as good as that of
Light’s criteria. By applying Light’s criteria to our study, we
obtained diagnostic parameters that were similar to those
found in the original study. Because the diagnostic accuracy of
the two criteria are comparable, the new criteria can be used
as a useful biochemical marker to suggest exudative effusions
and can be used in day-to-day laboratory practice.
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